Medicover Integrated Clinical Services.

UNQUESTIONABLE LEADER IN THE REGION

Medicover’s Diagnostic Services offers more than 3,000 parameters ranging from routine blood tests to highly advanced diagnostics, covering all major clinical pathology areas:

Allergy and autoimmune diagnostics
Bacteriology
Parasitology
Biochemistry and immunochemistry
Blood groups diagnostics / transfusion medicine
Tumor markers
Clinical chemistry
Cytology
Hematology
Histopathology
Human genetics
Hygiene
Immunology and immunochemistry
Infectious diseases
Microbiology
Molecular biology
PK & PD
Pharmacology / toxicology

Medicover regularly upgrades and invests in best in class laboratory equipment. Fully integrated automations from industry leaders Roche, Beckman Coulter and Sysmex are implemented in the high-throughput laboratory areas, each managing between 10,000-25,000 tests per day.

Advanced equipment in genetic testing features a NovaSeq™ High Throughput Next Generation Sequencer, a Hamilton based automation solution for DNA extraction, as well as a robust bioinformatics solution.

GENETICS

Medicover Genetics is a strategic business unit integrating the division’s extensive genetic testing capabilities. It was developed as a Greenfield approach including the acquisitions of several key institutions in Germany to build a strong foundation for our ambition to become a market leader in genetics.

Our purpose is to empower people to use comprehensive and meaningful genetic tests at the forefront of their diagnostic journey, fuelled by our vision to place genetics at the core of medical decisions. We want to achieve this by leveraging advancements in genomics to develop relevant diagnostic solutions, supported by professional medical interpretation, to improve people’s health and well-being.

Spanning cytogenetic analyses, molecular pathology solutions, the latest in Next Generation Sequencing (NGS) technology and microbiome sequencing, Medicover Genetics offers a complete in-house and tailor-made portfolio produced in our laboratories in Germany and offered internationally.

Medicover is the sole testing site in Europe for Bionano’s Saphyr® technology. The third-generation optical mapping solution aims to provide the missing information in genome research with rapid, high-throughput, long-range genome mapping and unmatched structural variation discovery capabilities. If proven successful, this technology will allow Medicover to resolve large-scale structural variations currently missed by NGS.

To operate smoothly on a global scale, while expanding the sample volume, we implemented an end-to-end clinical suite for a more robust diagnostics pipeline and a solution that could accommodate different geographic locations with one local installation. This allows us to make NGS testing and variant discovery efficient, scalable and accessible by converting NGS data into customized clinical reports in a timely manner.

For more information please visit: www.medicover-genetics.de

HISTOPATHOLOGY

Medicover’s Diagnostics Services offers histopathology testing and reporting service for hospitals and laboratories through its digital pathology platform in Serbia.

Digital pathology enables the acquisition, management and interpretation of pathology information by scanning a glass slide. In order to create a digital slide, the glass slides with the sample tissue are captured with a scanner, which results in a high-resolution digital image.

Using superior logistics, automation and an ever-growing portfolio of tests, we provide primary diagnostic testing and well as secondary opinion services globally.